Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Early blood glucose control for people with type 2 diabetes is crucial for reducing complications and prolonging life

DTU General Research

Research led by scientists from the Universities of Oxford and Edinburgh has found that early good blood glucose control can minimise the lifetime risk of diabetes-related complications, including heart attacks, kidney failure and vision loss.

The LEGEND-D Trial – which aims to prevent low blood sugar levels in type 1 diabetes – is open to recruitment


The first participant has completed initial study activities and is now randomised to one of the trial’s arms.

DTU to run clinical trial for Dementias Platform UK in nationwide bid to revolutionise dementia diagnosis using blood tests

DTU General

Dementias Platform UK has been awarded over £4 million to carry out countrywide trials to identify accurate and quick blood tests that can diagnose dementia, in a bid to improve management and patient and carer wellbeing. RDM's Diabetes Trials Unit will run the clinical trial component of the challenge.

UK’s first registry to be set up for those at risk of type 1 diabetes

DTU Research

Researchers from the Oxford BRC and other collaborating organisations have received funding to set up a UK registry for children and adults who are at risk of type 1 diabetes and have tested positive for diabetes autoantibodies.

Professor Rury Holman wins 2024 Banting Medal for Scientific Achievement

Awards DTU Department General OCDEM

The American Diabetes Association (ADA) has announced this year's National Scientific and Health Care Achievement Award recipients.

Trial of ‘artificial pancreas’ for people with cystic fibrosis-related diabetes is off to a strong start


The first group of participants recruited into the CL4P-CF trial is helping to test the effect of using an automated insulin delivery system in people with cystic fibrosis-related diabetes.

Live to eat and eat to live longer


New research shows that following the Eatwell Guide recommendations or longevity-associated dietary patterns is likely to improve life expectancy in people with unhealthy or typical dietary patterns in the UK.

How to be a good Chief Investigator: one-day UKCRC CTU Network-supported workshops


Do you know a Chief Investigator who would like a refresher on how to interact with a clinical trials unit (CTU)? Or one who is about to work with you and wants to get up to speed? Or perhaps someone initially considering working with a CTU?

Intensive blood glucose control for people with type 2 diabetes when they are first diagnosed reduces diabetic complications and prolongs life

DTU Department General OCDEM Research

The study, which tracked volunteers for up to 44 years, showed that the benefits of early intensive blood glucose control can persist for decades.

Early blood-sugar levels in type 2 diabetes crucial for future prognosis

DTU Department General OCDEM Publication Research

People who get type 2 diabetes need to gain control of their blood-sugar levels — fast. The years immediately after diagnosis are strikingly critical in terms of their future risk for heart attacks and death.

Load More

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with